This was the stock's third consecutive day of losses.
The teen is the first student from Levittown's General Douglas MacArthur High School to be named a finalist in the ...
1don MSN
We recently published a list of the 11 Best Pharma Stocks to Buy According to Hedge Funds. In this article, we are going to ...
Regeneron’s DB-OTO: Overcoming Clinical and Manufacturing Hurdles in Gene Therapy for Hearing Loss
Jonathon Whitton, AuD, PhD, VP, auditory global program head, Regeneron, discusses regulatory challenges for DB-OTO, Regeneron’s AAV-based gene therapy for hearing loss.
Wen is among the 40 finalists heading to Washington, D.C., Thursday to present their projects to panels of experts. The ...
2h
ABC11 on MSNSmithfield teen takes second in national science contest for research on Native American myopathyAva Grace Cummings is still on cloud 9 after placing 2nd in the 2025 Regeneron Science Talent Search. The Johnston County teenager is a senior at the North Carolina School of Science and Math in ...
Regeneron Pharmaceuticals (REGN) and Sanofi (SNY) presented positive results from the pivotal ADEPT Phase 2/3 trial evaluating the ...
At the CIO 100 Symposium and Awards, Lee Rennick, executive director of CIO Communities for CIO.com, sat with Bob McCowan, SVP and CIO at Regeneron Pharmaceuticals, and discussed their award-winning ...
We hear from the student winners of the prestigious Regeneron Science Talent Search, America's oldest science and math competition.
Regeneron Pharmaceuticals, Inc. ( NASDAQ: REGN) Leerink Partners 2025 Global Healthcare Conference Call March 11, 2025 8:00 AM ET ...
It has been about a month since the last earnings report for Regeneron (REGN). Shares have lost about 4.1% in that time frame, underperforming the S&P 500. Will the recent negative trend continue ...
This was the stock's second consecutive day of losses.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results